The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...
The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...
The IsoPSA test is intended to help assess whether patients with elevated PSA levels should go on to receive a biopsy ...
NEW YORK (Reuters Health) - Most older men with prostate cancer found by prostate-specific antigen (PSA) tests and biopsies opted for treatment in a new study - even if signs pointed to their disease ...
DEAR DR. ROACH: I am a 53-year-old healthy male, and I always request to check my PSA levels each year. My 57-year-old brother’s new doctor denied his request for a routine PSA check on their initial ...
The PSA test is an imperfect way to screen men for prostate cancer. But until recently, it was seen as the best option available. The test measures the amount of prostate specific antigen, or PSA, in ...
A urine test could have avoided one third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation study that included more than 1,500 ...
The Prostate Health Index (phi) (Beckman Coulter) significantly changes urologists' opinions about whether men with certain results on prostate-specific antigen (PSA) screening should or should not ...
The recommendation Monday by the prestigious United States Preventive Services Task Force (USPSTF) that the widely used PSA test for prostate cancer no longer be used routinely for men of any age is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback